Early trial of new vaccine shows promise for people with Lynch syndrome
https://www.facingourrisk.org/XRAY/lynch-syndrome-cancer-vaccine
Full article: https://www.nature.com/articles/s41591-025-04182-9
The Nous-209 vaccine for preventing cancer in people with Lynch syndrome was tested in an early-phase study. The safety and immune response results were encouraging. An immune response was seen in most participants, suggesting that the vaccine may help reduce the chance of developing cancer in people with Lynch syndrome.
Questions To Ask Your Health Care Provider
- Do you think this vaccine might be an option for me now or in the future?
- Would I be eligible for the next clinical trial testing this vaccine?
- How can I find out when the next trial enrolls patients?
- Are there other clinical trials for people with Lynch syndrome that I should know about?
- Should I continue to take high-dose aspirin to prevent cancer?
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.